000 | 01797 a2200553 4500 | ||
---|---|---|---|
005 | 20250517032452.0 | ||
264 | 0 | _c20150911 | |
008 | 201509s 0 0 eng d | ||
022 | _a1938-3207 | ||
024 | 7 |
_a10.3945/ajcn.114.102681 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWebb, Penelope M | |
245 | 0 | 0 |
_aCirculating 25-hydroxyvitamin D and survival in women with ovarian cancer. _h[electronic resource] |
260 |
_bThe American journal of clinical nutrition _cJul 2015 |
||
300 |
_a109-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAustralia |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 | _aDietary Supplements |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLife Style |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xblood |
650 | 0 | 4 |
_aOvarian Neoplasms _xdiagnosis |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSocioeconomic Factors |
650 | 0 | 4 | _aSurveys and Questionnaires |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aVitamin D _xanalogs & derivatives |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _ade Fazio, Anna | |
700 | 1 | _aProtani, Melinda M | |
700 | 1 | _aIbiebele, Torukiri I | |
700 | 1 | _aNagle, Christina M | |
700 | 1 | _aBrand, Alison H | |
700 | 1 | _aBlomfield, Penelope I | |
700 | 1 | _aGrant, Peter | |
700 | 1 | _aPerrin, Lewis C | |
700 | 1 | _aNeale, Rachel E | |
773 | 0 |
_tThe American journal of clinical nutrition _gvol. 102 _gno. 1 _gp. 109-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3945/ajcn.114.102681 _zAvailable from publisher's website |
999 |
_c24898286 _d24898286 |